The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 68.60
Ask: 70.00
Change: 0.60 (0.89%)
Spread: 1.40 (2.041%)
Open: 68.40
High: 69.60
Low: 68.20
Prev. Close: 67.60
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Annual General Meeting 2018

4 Sep 2018 16:00

RNS Number : 7516Z
Severfield PLC
04 September 2018
 

SEVERFIELD PLC

Results of Annual General Meeting 2018

At the Company's Annual General Meeting held at 12 noon today, 4 September, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at http://www.hemscott.com/nsm.do.

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

In Favour

Against

Total

Withheld

Resolution

No of votes

% of votes

No of votes

% of votes

No of votes

No of votes

1. To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 31 March 2018 together with the report of the auditors thereon.

238,057,361

99.52

1,156,584

0.48

239,213,945

0

2. To approve the Directors' remuneration report (other than the part containing the Directors' remuneration policy) for the financial year ended 31 March 2018 as set out in the Annual Report and Accounts 2018.

239,005,356

99.95

114,588

0.05

239,119,944

94,000

3. To declare a final dividend of 1.7p per ordinary share in respect of the year ended 31 March 2018 payable on 14th September 2018 to shareholders on the register at the close of business on 17th August 2018.

239,213,945

100.00

0

0.00

239,213,945

0

4. To declare a special dividend of 1.7p per ordinary share in respect of the year ended 31 March 2018 payable on 14 September 2018 to shareholders on the register at the close of business on 17 August 2018.

239,213,945

100.00

0

0.00

239,213,945

0

5. To reappoint John Dodds as a Director.

212,191,476

97.11

6,319,811

2.89

218,511,287

20,702,657

6. To reappoint Ian Cochrane as a Director.

232,919,620

97.37

6,287,325

2.63

239,206,945

7,000

7. To reappoint Alan Dunsmore as a Director.

232,927,702

97.37

6,279,243

2.63

239,206,945

7,000

8. To reappoint Derek Randall as a Director.

232,907,951

97.38

6,273,994

2.62

239,181,945

32,000

9. To reappoint Adam Semple as a Director.

232,902,068

97.36

6,304,877

2.64

239,206,945

7,000

10. To reappoint Alun Griffiths as a Director.

234,926,083

98.21

4,272,112

1.79

239,198,195

15,749

11. To reappoint Tony Osbaldiston as a Director.

234,937,532

98.22

4,267,112

1.78

239,204,644

9,300

12. To reappoint Kevin Whiteman as a Director.

233,404,990

97.57

5,801,954

2.43

239,206,944

7,000

13. To reappoint KPMG LLP as auditors of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2019.

238,966,574

99.94

137,371

0.06

239,103,945

110,000

14. To authorise the Directors to determine the auditors' remuneration.

239,089,582

99.95

117,030

0.05

239,206,612

7,333

15. To authorise the Directors to allot securities of the Company.

239,027,102

99.94

152,025

0.06

239,179,127

29,348

16. To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company.

239,027,658

99.93

161,287

0.07

239,188,945

25,000

17. To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or specified capital investment.

237,309,978

99.26

1,760,466

0.74

239,070,444

143,500

18. To authorise the Company to make market purchases of the Company's ordinary shares.

237,376,810

99.25

1,789,286

0.75

239,166,096

47,848

19. That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice.

238,119,733

99.56

1,050,712

0.44

239,170,445

43,500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFKQDQQBKDFCK
Date   Source Headline
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration
23rd Nov 20217:00 amRNSInterim Results
9th Nov 202112:53 pmRNSIssue of Ordinary Shares
29th Oct 202112:55 pmRNSIssue of Ordinary Shares
19th Oct 20212:30 pmRNSDirector/PDMR Shareholding
13th Oct 20214:35 pmRNSPrice Monitoring Extension
13th Oct 202111:30 amRNSDirector/PDMR Shareholding - AMENDED
12th Oct 20215:43 pmRNSDirector/PDMR Shareholding
12th Oct 202110:45 amRNSIssue of Ordinary Shares
5th Oct 202112:47 pmRNSDirector/PDMR Shareholding
4th Oct 20214:08 pmRNSDirector/PDMR Shareholding
29th Sep 202112:39 pmRNSIssue of Ordinary Shares
28th Sep 20215:56 pmRNSDirector/PDMR Shareholding
21st Sep 202111:16 amRNSIssue of Ordinary Shares
20th Sep 20213:39 pmRNSDirector/PDMR Shareholding
17th Sep 202111:28 amRNSDirector / PDMR Shareholding
14th Sep 202111:45 amRNSIssue of Ordinary Shares
14th Sep 20218:00 amRNSEdison Investment Research Limited: Applied Graphene Materials (AGM): Initiation - Delivering the potential of graphene
13th Sep 20217:00 amEQSSeverfield (SFR): Positive start to FY22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.